Mitrany Rayten Michal Ety 4

What Happened
Mitrany Rayten (director) sold a total of 17,980 Brainsway ordinary shares in two open-market transactions: 10,000 shares on May 25, 2026 at NIS 45.5588/share (~NIS 455,588) and 7,980 shares on May 26, 2026 at NIS 44.7516/share (~NIS 357,118). Combined proceeds were about NIS 812,706. These were sales (not purchases), which are often routine insider liquidity events and do not by themselves indicate company prospects.

Key Details

• Transaction dates and prices:
  • May 25, 2026 — 10,000 shares sold at NIS 45.5588/share (~NIS 455,588) (footnote F2)
  • May 26, 2026 — 7,980 shares sold at NIS 44.7516/share (~NIS 357,118) (footnote F4)
• Total shares sold: 17,980; approximate total proceeds: NIS 812,706.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Notable footnotes:
  • F1: Ordinary shares may be represented by American Depositary Shares (each ADS currently = 1 Ordinary Share).
  • F3: Filing notes the insider also has unvested RSUs to receive 6,250 ordinary shares that vest quarterly through March 5, 2028 (each RSU = contingent right to one share).
• Filing timeliness: Filed May 26, 2026 for transactions on May 25–26, within the standard Form 4 reporting window (timely).

Context
Sales by directors are common for diversification or liquidity and should be interpreted as data, not a direct signal of company performance. The filing shows straightforward open-market dispositions; there is no indication here of option exercises, gifts, or a 10b5-1 plan noted in the disclosure.